Figure 1
Incidence of Gastrointestinal side effects before and after switchover to extended release metformin XR in patients completing the 6 month study. * vs metformin p = 0.013.
Figure 1 | Diabetology & Metabolic Syndrome
Incidence of Gastrointestinal side effects before and after switchover to extended release metformin XR in patients completing the 6 month study. * vs metformin p = 0.013.